NOLASCO, SANTI
 Distribuzione geografica
Continente #
NA - Nord America 390
EU - Europa 212
AS - Asia 150
AF - Africa 60
SA - Sud America 12
Totale 824
Nazione #
US - Stati Uniti d'America 390
IT - Italia 152
SG - Singapore 98
CI - Costa d'Avorio 40
CN - Cina 33
IE - Irlanda 25
SN - Senegal 19
BR - Brasile 9
NL - Olanda 9
RU - Federazione Russa 8
FI - Finlandia 6
IN - India 6
DE - Germania 5
GB - Regno Unito 4
ES - Italia 3
IQ - Iraq 3
HK - Hong Kong 2
JP - Giappone 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
EC - Ecuador 1
KE - Kenya 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
TR - Turchia 1
Totale 824
Città #
Santa Clara 190
Singapore 64
Abidjan 40
Chicago 39
Civitanova Marche 36
Boardman 31
Dublin 25
Ashburn 21
Dakar 19
Milan 18
Catania 14
Biancavilla 6
Bologna 6
Council Bluffs 5
Pune 5
Seattle 5
Los Angeles 4
Munich 4
Rome 4
Verona 4
Astoria 3
Giarre 3
Helsinki 3
Lappeenranta 3
Madrid 3
Mascalucia 3
Naples 3
Reggio Emilia 3
Abbiategrasso 2
Amsterdam 2
Bitonto 2
Bruneck 2
Cagliari 2
Corato 2
Corsico 2
Laives 2
New York 2
Phoenix 2
Rimini 2
Tai Wan 2
Taoyuan District 2
Tokyo 2
Ankara 1
Aracaju 1
Ba'qubah al Jadidah 1
Baghdad 1
Bahawalpur 1
Bogotá 1
Cesa 1
Dongguan 1
Dordrecht 1
Erbil 1
Fortaleza 1
Genoa 1
Giugliano in Campania 1
Gravina di Catania 1
Jaboatão dos Guararapes 1
João Monlevade 1
Kolkata 1
La Concordia 1
Lambaré 1
Messina 1
Monzuno 1
Nairobi 1
Olinda 1
Praia Grande 1
Sant'Anastasia 1
Santa Luzia 1
São Paulo 1
Trabia 1
Washington 1
Xiangtan 1
Águas Lindas de Goiás 1
Totale 623
Nome #
High-Flow Nasal Cannula Oxygen Therapy: Physiological Mechanisms and Clinical Applications in Children 89
Acute and long-term management of severe bronchiectasis with high flow nasal therapy: A case report 43
Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study 42
Real-life effects of dupilumab in patients with severe type 2 asthma, according to atopic trait and presence of chronic rhinosinusitis with nasal polyps 41
Type 2-High Severe Asthma with and without Bronchiectasis: A Prospective Observational Multicentre Study 41
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study 41
Tezepelumab for asthma 37
Long-Term Domiciliary High-Flow Nasal Therapy in Patients with Bronchiectasis: A Preliminary Retrospective Observational Case-Control Study 35
Benralizumab Effectiveness in Severe Eosinophilic Asthma with Co-Presence of Bronchiectasis: A Real-World Multicentre Observational Study 34
High-flow nasal oxygen versus conventional oxygen therapy in patients with COVID-19 pneumonia and mild hypoxaemia: a randomised controlled trial 33
Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression 32
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program 31
Mepolizumab effectiveness in patients with severe eosinophilic asthma and co-presence of bronchiectasis: A real-world retrospective pilot study 29
Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy 29
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 29
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 27
Comparability of asthma control test scores between self and physician-administered test 27
Personalized Medicine in Asthma: Current Approach and Future Perspectives 25
Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience 25
Are we overlooking the lung function in the definition of severe asthma remission? 23
Switching Biological Therapies in Severe Asthma 23
Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission 21
Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis 20
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study 20
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super‐Response and Remission With Mepolizumab 20
Eosinophilic Bronchiectasis: Prevalence, Severity, and Associated Features—A Cohort Study 17
Depemokimab, the first ultra-long-acting anti-IL-5 monoclonal antibody for severe eosinophilic asthma 11
Impact of Long-Term High-Flow Nasal Therapy on Mucus Plugs in Patients with Bronchiectasis 6
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study 6
Totale 857
Categoria #
all - tutte 4.347
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.347


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202389 0 0 0 0 0 0 25 29 20 4 2 9
2023/2024224 6 29 22 19 6 47 4 21 3 8 44 15
2024/2025544 15 87 53 48 146 114 40 23 18 0 0 0
Totale 857